查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1611028

美國醫療設備製造商市場規模、佔有率和趨勢分析報告：按應用、細分市場預測，2025-2030年

U.S. Medical Device Manufacturers Market Size, Share & Trends Analysis Report By Application, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 137 Pages | 商品交期: 2-10個工作天內

價格

美國醫療設備製造商市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計2030年美國醫療設備製造商市場規模將達3,601億美元，2025年至2030年複合年成長率為5.9%。

該區域市場主要是由該國高額醫療保健支出推動的。預計老年人口的增加和慢性病盛行率的上升也將促進預測期內的市場成長。

COVID-19 大流行引發了對手套、注射器、口罩、個人防護套件、紅外線體溫計、脈動式血氧監測儀系統和檢測套組等醫療消耗品和病患輔助用具的需求急劇增加。這為現有參與者和新進入者創造了巨大的商機。然而，疫情也導致減重手術、關節重建手術和整容手術等擇期手術大幅減少，限制了上述手術中使用的醫療設備的成長。從 2021 年中開始，由於政府為重啟擇期手術做出了積極努力，市場預計將復甦。

在美國，醫療設備研發投入不斷加大，尖端技術採用率較高，為醫療設備製造商創造了理想的商業環境。該國擴大採用微創手術也推動了市場的發展。此外，由於意外事故以及久坐生活方式引起的疾病導致的病例增加預計將在預測期內推動市場成長。

美國有優惠的報銷政策，例如美國的醫療保險制度。波士頓科學公司 (Boston Scientific) 與醫療保險和醫療補助服務中心 (CMS) 合作，為 C 代碼涵蓋的流動支付分類 (APC) 範圍內的所有設備提供報銷。儘管這種有利的報銷結構預計將促進市場成長，但法規不斷變化的性質可能會受到突然修訂的影響，這可能會對市場產生重大影響。

美國醫療設備製造商市場報告亮點

  • 其他細分市場領先市場，佔 2024 年銷售額的 35.7%。此細分市場主要包括用於體外診斷、醫學影像、牙科、耳鼻喉 (ENT)、傷口護理和一般外科的設備。
  • 預計心臟病設備在預測期內的複合年成長率將達到 7.7%，是最快的。
  • 根據 CDC 2023 年 5 月發表的報導，心血管疾病每 33 秒就會導致 1 人死亡，醫療設備的市場需求龐大。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章美國醫療設備製造商市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 美國醫療設備製造商市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章美國醫療設備製造商市場：應用預估及趨勢分析

  • 2024年及2030年應用市場佔有率
  • 細分儀表板
  • 美國醫療設備製造商按應用市場前景
  • 2018-2030年市場規模及預測及趨勢分析
    • 整形外科設備
    • 心血管設備
    • 神經病學設備
    • 藥物輸送裝置
    • 眼科設備
    • 腎臟科/泌尿系統設備
    • 其他

第5章競爭狀況

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商情況
    • 2024年主要企業市場佔有率分析
    • Stryker
    • Cardinal Health
    • Eli Lily and Company
    • Intuitive Surgical
    • Edwards Lifesciences Corporation
    • BD
    • Danaher
    • 3M
    • Abbott
    • Baxter
    • B. Braun SE
    • GE HealthCare
    • Johnson &Johnson Services, Inc.
    • Medtronic
    • Boston Scientific Corporation
Product Code: GVR-3-68038-032-3

U.S. Medical Device Manufacturers Market Growth & Trends:

The U.S. medical device manufacturers market size is expected to reach USD 360.1 billion by 2030, registering a CAGR of 5.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. The regional market is significantly driven by the high healthcare expenditure of the country. The increasing geriatric population coupled with the rising prevalence of chronic diseases is also expected to augment the market growth over the forecast period.

The COVID-19 pandemic triggered a drastic rise in demand for medical consumables and patient aids, such as gloves, syringes, masks, PPE kits, infrared thermometers, pulse oximeter, testing kits, etc. This resulted in an immense opportunity for the existing players as well as new entrants. However, the pandemic also resulted in a massive reduction in elective procedures, such as bariatric surgeries, joint replacement surgeries, cosmetic surgeries, etc., thus restricting the growth of medical devices used in the aforementioned procedures. The market recovery can be expected from mid-2021 onwards with favorable government initiatives to re-launch elective procedures.

Growing investments in medical device R&D along with the high adoption rate of advanced technology in the U.S., create the perfect business environment for medical device manufacturers in the country, providing them with lucrative opportunities to accelerate their business operations. Increasing adoption of minimally invasive surgeries in the country is also driving the market. In addition, rising cases of accidental injuries coupled with diseases caused due to sedentary lifestyle will propel the market growth over the forecast period.

The U.S. has favorable reimbursement policies such as the U.S. Medicare system. Boston Scientific Corp., in association with the Centers for Medicare and Medicaid Services (CMS), offers reimbursement for all devices that fall under Ambulatory Payment Classifications (APCs), covered under C-codes. These favorable reimbursement structures are expected to fuel market growth; however, the ever-evolving nature of regulations may lead to abrupt amends, which may significantly impact the market.

U.S. Medical Device Manufacturers Market Report Highlights:

  • The others segment led the market and accounted for 35.7% of the revenue in 2024. The segment primarily comprises devices used in IVD diagnostics, medical imaging, dental, ear-nose-and-throat (ENT), wound care, and general surgery.
  • Cardiology devices are expected to register the fastest CAGR of 7.7% over the forecast period.
  • Heart diseases are one of the leading causes of mortality in the U.S. According to a CDC article published in May 2023, the high mortality, with one death due to cardiovascular disease every 33 seconds, creates a substantial market demand for innovative medical devices that can contribute to the prevention, early diagnosis, & effective treatment of heart-related conditions.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in the U.S.
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Medical Device Manufacturers Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing geriatric population
      • 3.2.1.2. High adoption of minimally invasive procedures
      • 3.2.1.3. Increase in the number of sports and road accidents
      • 3.2.1.4. Increasing geographic reach of market players
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Increase in the number of product recalls
      • 3.2.2.2. Social and ethical issues
      • 3.2.2.3. Slow approval procedures
  • 3.3. U.S. Medical Device Manufacturers Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic Landscape

Chapter 4. U.S. Medical Device Manufacturers Market: Application Estimates & Trend Analysis

  • 4.1. Application Market Share, 2024 & 2030
  • 4.2. Segment Dashboard
  • 4.3. U.S. Medical Device Manufacturers Market by Application Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Orthopedic Devices
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.2. Cardiovascular Devices
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.3. Neurology Devices
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.4. Drug Delivery Devices
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.5. Ophthalmic Devices
      • 4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.6. Nephrology and Urology Devices
      • 4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.7. Others
      • 4.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. Competitive Landscape

  • 5.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 5.2. Company/Competition Categorization
  • 5.3. Vendor Landscape
    • 5.3.1. Key company market share analysis, 2024
    • 5.3.2. Stryker
      • 5.3.2.1. Company overview
      • 5.3.2.2. Financial performance
      • 5.3.2.3. Product benchmarking
      • 5.3.2.4. Strategic initiatives
    • 5.3.3. Cardinal Health
      • 5.3.3.1. Company overview
      • 5.3.3.2. Financial performance
      • 5.3.3.3. Product benchmarking
      • 5.3.3.4. Strategic initiatives
    • 5.3.4. Eli Lily and Company
      • 5.3.4.1. Company overview
      • 5.3.4.2. Financial performance
      • 5.3.4.3. Product benchmarking
      • 5.3.4.4. Strategic initiatives
    • 5.3.5. Intuitive Surgical
      • 5.3.5.1. Company overview
      • 5.3.5.2. Financial performance
      • 5.3.5.3. Product benchmarking
      • 5.3.5.4. Strategic initiatives
    • 5.3.6. Edwards Lifesciences Corporation
      • 5.3.6.1. Company overview
      • 5.3.6.2. Financial performance
      • 5.3.6.3. Product benchmarking
      • 5.3.6.4. Strategic initiatives
    • 5.3.7. BD
      • 5.3.7.1. Company overview
      • 5.3.7.2. Financial performance
      • 5.3.7.3. Product benchmarking
      • 5.3.7.4. Strategic initiatives
    • 5.3.8. Danaher
      • 5.3.8.1. Company overview
      • 5.3.8.2. Financial performance
      • 5.3.8.3. Product benchmarking
      • 5.3.8.4. Strategic initiatives
    • 5.3.9. 3M
      • 5.3.9.1. Company overview
      • 5.3.9.2. Financial performance
      • 5.3.9.3. Product benchmarking
      • 5.3.9.4. Strategic initiatives
    • 5.3.10. Abbott
      • 5.3.10.1. Company overview
      • 5.3.10.2. Financial performance
      • 5.3.10.3. Product benchmarking
      • 5.3.10.4. Strategic initiatives
    • 5.3.11. Baxter
      • 5.3.11.1. Company overview
      • 5.3.11.2. Financial performance
      • 5.3.11.3. Product benchmarking
      • 5.3.11.4. Strategic initiatives
    • 5.3.12. B. Braun SE
      • 5.3.12.1. Company overview
      • 5.3.12.2. Financial performance
      • 5.3.12.3. Product benchmarking
      • 5.3.12.4. Strategic initiatives
    • 5.3.13. GE HealthCare
      • 5.3.13.1. CompanOverviewew
      • 5.3.13.2. Financial performance
      • 5.3.13.3. Product benchmarking
      • 5.3.13.4. Strategic initiatives
    • 5.3.14. Johnson & Johnson Services, Inc.
      • 5.3.14.1. CompanOverviewew
      • 5.3.14.2. Financial performance
      • 5.3.14.3. Product benchmarking
      • 5.3.14.4. Strategic initiatives
    • 5.3.15. Medtronic
      • 5.3.15.1. Company overview
      • 5.3.15.2. Financial performance
      • 5.3.15.3. Product benchmarking
      • 5.3.15.4. Strategic initiatives
    • 5.3.16. Boston Scientific Corporation
      • 5.3.16.1. CompanOverviewew
      • 5.3.16.2. Financial performance
      • 5.3.16.3. Product benchmarking
      • 5.3.16.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. Medical Device Manufacturers market revenue estimates and forecast, by application, 2018 - 2030 (USD Billion)
  • Table 4 Key companies undergoing acquisitions/expansions
  • Table 5 Key companies undergoing product launch/approval
  • Table 6 Key companies undergoing partnership & collaboration

List of Figures

  • Fig. 1 U.S. Medical Device Manufacturers Market Segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market snapshot
  • Fig. 8 Competitive landscape
  • Fig. 9 Market Dynamics
  • Fig. 10 U.S. Medical Device Manufacturers market: PORTER's analysis
  • Fig. 11 U.S. Medical Device Manufacturers market: PESTEL analysis
  • Fig. 12 U.S. Medical Device Manufacturers market: by application: key takeaways
  • Fig. 13 U.S. Medical Device Manufacturers market, by application: market share, 2024 & 2030
  • Fig. 14 Orthopedic devices market, 2018 - 2030 (USD Billion)
  • Fig. 15 Cardiovascular devices market, 2018 - 2030 (USD Billion)
  • Fig. 16 Neurology devices market, 2018 - 2030 (USD Billion)
  • Fig. 17 Drug delivery devices market, 2018 - 2030 (USD Billion)
  • Fig. 18 Ophthalmic devices market, 2018 - 2030 (USD Billion)
  • Fig. 19 Nephrology and urology devices market, 2018 - 2030 (USD Billion)
  • Fig. 20 Others market, 2018 - 2030 (USD Billion)
  • Fig. 21 Key company categorization
  • Fig. 22 Heat map analysis
  • Fig. 23 U.S orthopedic devices market share analysis, 2024
  • Fig. 24 U.S cardiac care devices market share analysis, 2024
  • Fig. 25 U.S drug delivery devices market share analysis, 2024
  • Fig. 26 Strategic Framework